Open banking is set to officially launch in Nigeria by August 2025, marking a new era for data driven financial services. With the Central Bank’s framework in place, the system promises innovation and inclusion but also raises questions around privacy, security, and compliance.

This article delves into the role of compulsory licensing as a legal mechanism for facilitating access to patented pharmaceuticals in the context of public health emergencies. While patents are essential in fostering pharmaceutical innovation, they often impose barriers to access in low-income regions. International legal frameworks, particularly the TRIPS Agreement and the Doha Declaration, empower nations to issue compulsory licenses, enabling the appropriation of patented technologies without the holder’s consent to prioritise public health needs.

This discussion highlights the critical necessity for robust legal structures that balance the protection of intellectual property rights with the imperative to ensure that life-saving therapies are accessible during health crises.

Nigeria, a trailblazer in African sustainable finance, has emerged as a key player in the global green bond market, with its sovereign green bonds being the first of their kind in Africa. This article examines the burgeoning green bond landscape in Nigeria, driven by government commitment, expanding institutional participation, and growing investor appetite for ESG-linked investments. It delves into the regulatory environment, highlighting the crucial roles of the Securities and Exchange Commission (SEC), the Nigerian Stock Exchange (NGX), and the Central Bank of Nigeria (CBN).